Adma Biologics reported $3.12B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 2.7B 757M Nov/2026
Alnylam Pharmaceuticals USD 33.02B 7.17B Sep/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
Novavax USD 1.09B 316M Dec/2025
Takeda JPY 9.26T 1.06T Sep/2026